Search Results 11-20 of 16615 for Inhibition
Investigators in the Mayo Clinic Ovarian Cancer SPORE are assessing DNA topoisomerase I (TOP1) inhibitors to treat ovarian cancer.
About this study. The primary objective of this Phase 2 study is to evaluate the efficacy and safety of a single antegrade intracoronary artery infusion of ...
... inhibition (AMI).The focus of the study is to develop an objective, reproducible, and reliable measure of neuromotor activation (directly correlated with ...
The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. Participation eligibility.
The purpose of this study is to see if treating patients who have high levels of donor specific alloantibodies post-transplant with bortezomib might prevent the ...
Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects With Elevated Risk · Overview · Participation eligibility · Participating Mayo Clinic ...
About this study. The primary purpose of this study is to find out what effects (good or bad) the drugs auranofin and sirolimus have on patients with lung ...
Check with your doctor or nurse immediately if any of the following side effects occur: More common. Chest pain or tightness; head congestion; hoarseness or ...
Mayo Clinic Hepatobiliary SPORE researchers are examining the cellular mechanisms for development of intrahepatic cholangiocarcinoma (cancer of the bile ...
Carbonic anhydrase inhibitors may pass into the breast milk. These medicines are not recommended during breast-feeding, because they may cause unwanted effects ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.